Abstract

The present application discloses a catalyst with a perovskite structure, a method for preparing the same, and a dry reforming method using the same. The catalyst is represented by A1-yA′yTi1-xRuxO3 and includes Ru nanoparticles exsoluted onto the catalyst surface. In the formula, A is Sr, Ca, or a combination thereof, A′ is La, Y, or a combination thereof, x is greater than 0 and less than or equal to 0.5, and y is greater than 0 and less than 1.0. The catalyst has the effect of maximizing the conversion rates of methane and carbon dioxide by maximizing the active sites for dry reforming reaction as well as thermal stability.

IPC Classes  ?

• B01J 23/63 - Platinum group metals with rare earths or actinides
• B01J 23/46 - Ruthenium, rhodium, osmium or iridium
• B01J 35/00 - Catalysts, in general, characterised by their form or physical properties
• B01J 35/70 - Catalysts, in general, characterised by their form or physical properties characterised by their crystalline properties, e.g. semi-crystalline
• B01J 37/08 - Heat treatment

Abstract

The present invention relates to a composition for preventing or treating bone and muscle disease comprising Eubacterium nodatum or a culture thereof. The present composition comprising Eubacterium nodatum or a culture thereof have the effect of increasing bone density, bone area, bone volume and bone thickness, increasing grip strength and muscle weight, and improving athletic performance.

IPC Classes  ?

• A61K 35/74 - Bacteria
• A61P 19/08 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
• A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system

Abstract

The present invention relates to a conductive material with high stretchability and a method for preparing the conductive material, and more particularly, to a conductive material with high stretchability, including a carbon nanotube (CNT) network, and a polymer dopant, not an elastomer, providing an increase in free-volume of the carbon nanotube (CNT) network, wherein the conductive material includes the polymer dopant in an amount of 1 wt % to less than 30 wt % with respect to the total weight of the carbon nanotubes (CNTs) and has stretchability.

IPC Classes  ?

• C08K 3/04 - Carbon
• C08J 3/20 - Compounding polymers with additives, e.g. colouring

Abstract

The present disclosure relates to a lipid nanoparticle composition including a gallic acid derivative lipid and a use thereof, wherein it is possible to improve delivery efficiency and immune effect by changing some of the compositions of lipid nanoparticles using a bio-friendly gallic acid derivative lipid and, in particular, if a gallic acid derivative replaces a certain ratio of an ionizable lipid in a molar composition ratio, it is possible to mitigate toxicity generated by the ionizable lipid, so as to be utilized for drug delivery more safely in vivo.

IPC Classes  ?

• A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
• A61K 9/1271 - Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
• A61K 9/51 - Nanocapsules
• A61K 39/00 - Medicinal preparations containing antigens or antibodies
• A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
• A61P 37/04 - Immunostimulants
• C12N 15/88 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using liposome vesicle

Abstract

A method and device for estimating a gaze distance of a user using hybrid scheme may accurately estimate a gaze distance of a user robustly against a difference in physiological characteristics of the user and a change in external environment using information of a binocular image and information of a depth image in a complementary manner by determining a final gaze distance of the user based on a first gaze distance of the user estimated based on a binocular convergence angle of the user and a second gaze distance of the user estimated based on a depth value of the gaze point of the user.

IPC Classes  ?

• G06T 7/593 - Depth or shape recovery from multiple images from stereo images
• G06T 7/60 - Analysis of geometric attributes
• G06T 7/73 - Determining position or orientation of objects or cameras using feature-based methods

Abstract

Disclosed herein is an apparatus and method for mass spectrometry using a nanostructure that enables measuring mass of an analyte in room temperature. The apparatus may include: a chamber providing a space in which mass spectrometry is performed; an analyte input unit configured to input an analyte into the chamber; a substrate disposed inside the chamber and having at least one nanostructure formed thereon, to which the analyte input by the analyte input unit is adsorbed; an electron beam generator configured to irradiate the nanostructure with an electron beam; a secondary electron detection unit configured to detect a secondary electron signal emitted by an interaction of the electron beam with the nanostructure; and a mass measurement unit configured to identify a vibrational state of the nanostructure and measure a mass of the nanostructure through frequency analysis of the detected secondary electron signal.

IPC Classes  ?

• H01J 49/00 - Particle spectrometers or separator tubes

Abstract

Disclosed is an intestinal macrophage-targeting prodrug nanoassembly for treating inflammatory bowel disease. The nanoassembly comprises a complex in which an inflammation therapeutic agent having an amine group is bonded to one end of a peptide represented by SEQ ID NO: 1, and the nanoassembly is formed by self-assembly of the complex via intermolecular interactions. The nanoassembly targets intestinal macrophages, is accumulated in inflammatory colon tissue, and regulates immune response to eventually promote differentiation into anti-inflammatory M2 macrophages, thereby providing excellent therapeutic efficacy against IBD.

IPC Classes  ?

• A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
• A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
• A61K 31/606 - Salicylic acidDerivatives thereof having amino groups
• A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
• A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system

Abstract

The present invention relates to an etching mask structure for fabricating a 3D mode converter and a method of manufacturing an optical waveguide having a 3D mode converter using the same, which allows an optical waveguide having a 3D mode converter to be capable of being manufactured through a simple process. The etching mask structure may include: an etching mask in the form of a bar, positioned in a process area where optical information processing is conducted, to prevent an optical waveguide film layer stacked on the process area from being etched when an etching process is performed; and supports each formed at both ends of the etching mask to support the etching mask.

IPC Classes  ?

• G02B 6/14 - Mode converters

Abstract

Mn+1n+1 Xnn n , where M is a transition metal element selected from the group consisting of Sc, Ti, V, Cr, Mn, Y, Zr, Nb, Mo, Hf, and Ta, X is carbon and/or nitrogen, and n is an integer of 1 to 4.

IPC Classes  ?

• C01B 32/907 - OxycarbidesSulfocarbidesMixture of carbides
• C09D 11/52 - Electrically conductive inks
• C09D 11/03 - Printing inks characterised by features other than the chemical nature of the binder
• H05K 9/00 - Screening of apparatus or components against electric or magnetic fields

Abstract

The present disclosure relates to a technology for controlling a robotic product. A cooperation control method of a multi-robot comprises detecting information on a user or information on surroundings of the user using sensors, recognizing an intention or a situational context of the user based on the detected information, selecting a task that a plurality of robots are able to cooperatively perform in response to the recognized intention or situational context of the user, and requesting a service provision to each of the plurality of robots that are able to cooperatively perform the selected task.

IPC Classes  ?

• B25J 9/16 - Programme controls
• B25J 9/00 - Programme-controlled manipulators

Abstract

The present disclosure relates to a thermoresponsive W/O/W (water-oil-water)-type emulsion composition comprising: an inner phase including water-in-oil type droplets containing a PCR primer and a probe; and an outer phase, which is an aqueous phase, a nucleic acid amplification device comprising the same, and a nucleic acid amplification method. According to the present disclosure, primers and/or probes required for nucleic acid detection or diagnosis are delivered through the thermoresponsive multi-emulsion composition, allowing for their stable storage until the PCR reaction begins, at which point they are released. Accordingly, non-specific reactions that may occur before PCR can be prevented, each composition can be prepared in a target-specific manner, and multiplex diagnosis can be implemented by simply performing PCR after nucleic acids extracted from a specimen are added to a reaction reagent containing the composition.

IPC Classes  ?

• C12Q 1/6876 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• C12Q 1/686 - Polymerase chain reaction [PCR]

Abstract

The present invention relates to an apparatus capable of simultaneously separating and recovering ammonia and phosphoric acid using a bipolar membrane electrodialysis device, wherein the apparatus can simultaneously separate and recover, with high efficiency, ammonia and phosphoric acid present in high-concentration organic wastewater. The apparatus capable of simultaneously separating and recovering ammonia and phosphoric acid using a bipolar membrane electrodialysis device, according to the present invention, comprises: a wastewater pre-processing tank that lowers the pH of wastewater; a wastewater supply tank that receives pre-processed wastewater from the wastewater pre-processing tank and supplies the pre-processed wastewater to the bipolar membrane electrodialysis device; the bipolar membrane electrodialysis device which simultaneously separates the ammonia and phosphoric acid contained in the wastewater; an ammonia concentrate tank that receives an ammonia concentrate from a base region (B) of the bipolar membrane electrodialysis device and stores the ammonia concentrate, wherein the ammonia concentrate is generated in the base region (B); and a phosphoric acid concentrate tank that receives a phosphoric acid concentrate from an acid region (A) of the bipolar membrane electrodialysis device and stores the phosphoric acid concentrate, wherein the phosphoric acid concentrate is generated in the acid region (A).

IPC Classes  ?

• C02F 1/469 - Treatment of water, waste water, or sewage by electrochemical methods by electrochemical separation, e.g. by electro-osmosis, electrodialysis, electrophoresis
• B01D 61/44 - Ion-selective electrodialysis
• B01D 61/46 - Apparatus therefor
• C02F 1/66 - Treatment of water, waste water, or sewage by neutralisationTreatment of water, waste water, or sewage pH adjustment
• C02F 1/52 - Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
• C02F 1/20 - Treatment of water, waste water, or sewage by degassing, i.e. liberation of dissolved gases
• B01D 53/22 - Separation of gases or vapoursRecovering vapours of volatile solvents from gasesChemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases or aerosols by diffusion

Abstract

Provided is a bearing test apparatus. The bearing test apparatus includes a chamber, a rotatable part of which a portion is inserted into the chamber, a fixed part configured to support the rotatable part, a support bearing inserted between the rotatable part and the fixed part to support rotation of the rotatable part, a cooling fluid supply device configured to supply a cooling fluid into the chamber, and a heating device connected to the support bearing. The heating device is configured to heat the support bearing.

IPC Classes  ?

• G01M 13/04 - Bearings

Abstract

The present disclosure discloses a catalyst for hydrogenolysis reaction of waste plastics, a method for producing the same, and a method for converting the waste plastics using the same. The catalyst comprises a ceria carrier; and a transition metal supported on the carrier. The catalyst has the effect of producing hydrocarbon compounds such as naphthas, fuels, and lubricants from waste plastics at a low temperature of 200 to 250° C.

IPC Classes  ?

• B01J 23/10 - Catalysts comprising metals or metal oxides or hydroxides, not provided for in group of rare earths
• B01J 23/63 - Platinum group metals with rare earths or actinides
• B01J 37/04 - Mixing
• B01J 37/08 - Heat treatment
• B01J 37/18 - Reducing with gases containing free hydrogen

Abstract

The present exemplary embodiments provide a manifold for a solid oxide fuel cell including: a first tube which is positioned on a side surface of the manifold and protrudes to the outside; a second tube which is positioned on a side surface of the manifold different from the surface on which the first tube is positioned and protrudes to the outside of the manifold; a fluid flow space connected to the first tube; and a plurality of branch tubes connected to the second tube, wherein the plurality of branch tubes is disposed inside the fluid flow space.

IPC Classes  ?

• H01M 8/2484 - Details of groupings of fuel cells characterised by external manifolds
• H01M 8/04007 - Auxiliary arrangements, e.g. for control of pressure or for circulation of fluids related to heat exchange
• H01M 8/0606 - Combination of fuel cells with means for production of reactants or for treatment of residues with means for production of gaseous reactants
• H01M 8/12 - Fuel cells with solid electrolytes operating at high temperature, e.g. with stabilised ZrO2 electrolyte
• H01M 8/1246 - Fuel cells with solid electrolytes operating at high temperature, e.g. with stabilised ZrO2 electrolyte characterised by the process of manufacturing or by the material of the electrolyte the electrolyte consisting of oxides
• H01M 8/2457 - Grouping of fuel cells, e.g. stacking of fuel cells with both reactants being gaseous or vaporised

Abstract

The present invention relates to a bifacial thin-film solar cell and a manufacturing method thereof, wherein, in implementing a CIGS-based bifacial thin-film solar cell, the interfacial resistance and recombination characteristics at an interface between a rear transparent electrode and CIGS are improved, thus making it possible to enhance rear-side photovoltaic performance. The bifacial thin-film solar cell according to the present invention is characterized by comprising: a rear transparent electrode stacked on a transparent substrate; a rear passivation layer stacked on the rear transparent electrode; a conductive thin film pattern formed in a partial region on the rear passivation layer; a light absorption layer stacked on the front surface of the rear passivation layer including the conductive thin film pattern; a buffer layer stacked on the light absorption layer; and a front transparent electrode stacked on the buffer layer.

IPC Classes  ?

• H01L 31/0216 - Coatings
• H01L 31/0468 - PV modules composed of a plurality of thin film solar cells deposited on the same substrate comprising specific means for obtaining partial light transmission through the module, e.g. partially transparent thin film solar modules for windows
• H01L 31/0392 - SEMICONDUCTOR DEVICES NOT COVERED BY CLASS - Details thereof characterised by their semiconductor bodies characterised by their crystalline structure or particular orientation of the crystalline planes including thin films deposited on metallic or insulating substrates
• H01L 31/032 - Inorganic materials including, apart from doping materials or other impurities, only compounds not provided for in groups
• H01L 31/0224 - Electrodes
• H01L 31/18 - Processes or apparatus specially adapted for the manufacture or treatment of these devices or of parts thereof

Abstract

The present invention relates to an anticancer cell therapeutic composition comprising immune cells expressing chimeric antigen receptors and traptavidin scaffold antibody-like proteins and a use thereof. The invention provides: an immune cell expressing a chimeric antigen receptor (CAR) that includes a biotin-tagged protein, and a co-stimulatory domain and an activation domain which are both capable of inducing an anticancer response; an antibody-like protein that contains a single-chain variable fragment (scFv) binding specifically to a tumor antigen, and traptavidin; wherein the antibody-like protein forms a tetramer through the self-binding of traptavidin and binds to a biotin-tagged protein expressed on the surface of the immune cell to allow the immune cell to have four single-chain variable fragments (scFvs), thereby providing an immune cell therapeutic agent having enhanced avidity to a tumor-specific antigen.

IPC Classes  ?

• C07K 14/705 - ReceptorsCell surface antigensCell surface determinants
• C07K 14/725 - T-cell receptors
• C07K 14/36 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from ActinomycesPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptomyces (G)
• C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
• C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
• A61K 39/00 - Medicinal preparations containing antigens or antibodies
• A61P 35/00 - Antineoplastic agents

Abstract

A transmitting and receiving device for quantum key distribution based on a chip comprising a base including one light entrance and exit; a first beam splitter, reflecting part of an optical signal incident through a first optical path on a second optical path and transmit a remaining part of the optical signal to a third optical path; a first modulator modulating a phase of an optical signal reflected from the first beam splitter and incident on the second optical path; a second modulator delaying the optical signal transmitted from the first beam splitter and incident on the third optical path for a predetermined period of time and modulate a phase of the optical signal; and a polarization splitter-rotator transmitting an optical signal incident from the second modulator, with a time difference relative to an optical signal incident from the first modulator, to the one light exit.

IPC Classes  ?

• H04B 10/532 - Polarisation modulation
• H04B 10/516 - Details of coding or modulation
• H04B 10/556 - Digital modulation, e.g. differential phase shift keying [DPSK] or frequency shift keying [FSK]
• H04B 10/67 - Optical arrangements in the receiver
• H04B 10/85 - Protection from unauthorised access, e.g. eavesdrop protection
• H04L 9/08 - Key distribution

Abstract

The present invention relates to a bifacial thin-film solar cell capable of enhancing photovoltaic performance on the rear side by reducing interfacial resistance and recombination characteristics at the interface between the rear transparent electrode and the CIGS in implementing a CIGS-based bifacial thin-film solar cell, and a manufacturing method thereof. The bifacial thin film solar cell according to the present invention is characterized by including: a rear transparent electrode stacked on a transparent substrate; a rear passivation layer stacked on the rear transparent electrode; a conductive thin film pattern formed in some regions on the rear passivation layer; a light-absorbing layer stacked on the front surface of the rear passivation layer including the conductive thin film pattern; a buffer layer stacked on the light-absorbing layer; and a front transparent electrode stacked on the buffer layer.

IPC Classes  ?

• H01L 31/0224 - Electrodes
• H01L 31/0216 - Coatings
• H01L 31/18 - Processes or apparatus specially adapted for the manufacture or treatment of these devices or of parts thereof

Abstract

The present invention provides a halogen-free MXene represented by the following formula (1), that has no halogen in its surface functional group by performing an etching process to generate MXene from a MAX Phase material, and after the etching process, performing an impurity removal treatment process of etching and removing impurities using a halogen-free etchant and a halogen-free post-treatment agent, respectively. The present invention provides a halogen-free MXene represented by the following formula (1), that has no halogen in its surface functional group by performing an etching process to generate MXene from a MAX Phase material, and after the etching process, performing an impurity removal treatment process of etching and removing impurities using a halogen-free etchant and a halogen-free post-treatment agent, respectively. Mn+1XnTx  [Formula 1] wherein, M is a transition metal element selected from the group consisting of Sc, Ti, V, Cr, Mn, Y, Zr, Nb, Mo, Hf, and Ta, X is at least one of carbon and nitrogen, and n is an integer from 1 to 4, and Tx is a functional group selected from the group consisting of oxygen, alkoxide of 1 to 5 carbon atoms, alkyl, carboxylate, hydroxide, hydride, oxide, sub-oxide, nitride, sub-nitride, sulfide, sulfonate, thiol, and epoxide.

IPC Classes  ?

• C01G 23/00 - Compounds of titanium

Abstract

Provided is a hydrogel composition including thermosensitive poly(phosphazene) to which a plurality of hydrophobic amino acids, hydrophilic polymers, and host molecules are substituted; and a physiologically active material linked to a guest molecule, wherein the poly(phosphazene) and the physiologically active material form a conjugate by inclusion of the guest molecule in the host molecule via a host-guest interaction.

IPC Classes  ?

• C08G 79/025 - Polyphosphazenes
• A61K 9/50 - Microcapsules
• A61K 38/04 - Peptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• C08J 3/075 - Macromolecular gels
• C08J 3/20 - Compounding polymers with additives, e.g. colouring
• C08J 3/24 - Crosslinking, e.g. vulcanising, of macromolecules

Abstract

The present invention relates to a proton conducting electrolyte powder, an electrolyte membrane, and a preparation method thereof. Specifically, the present invention relates to a heterophasic BCZYYb proton conducting electrolyte powder obtained using low-temperature solid synthesis at 1000 to 1200°C, a proton conducting electrolyte membrane with a monophasic BCZYYb (Ba,Ce,Zr,Y,Yb) composition prepared by sintering the proton conducting electrolyte powder at 1300 to 1500°C, and a preparation method of the proton conducting electrolyte membrane, comprising calcining and sintering at the temperature.

IPC Classes  ?

• H01M 8/1246 - Fuel cells with solid electrolytes operating at high temperature, e.g. with stabilised ZrO2 electrolyte characterised by the process of manufacturing or by the material of the electrolyte the electrolyte consisting of oxides
• H01M 8/1253 - Fuel cells with solid electrolytes operating at high temperature, e.g. with stabilised ZrO2 electrolyte characterised by the process of manufacturing or by the material of the electrolyte the electrolyte consisting of oxides the electrolyte containing zirconium oxide
• H01M 8/126 - Fuel cells with solid electrolytes operating at high temperature, e.g. with stabilised ZrO2 electrolyte characterised by the process of manufacturing or by the material of the electrolyte the electrolyte consisting of oxides the electrolyte containing cerium oxide
• C25B 13/07 - DiaphragmsSpacing elements characterised by the material based on inorganic materials based on ceramics
• C25B 1/04 - Hydrogen or oxygen by electrolysis of water
• C04B 35/50 - Shaped ceramic products characterised by their compositionCeramic compositionsProcessing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on rare earth compounds
• C04B 35/64 - Burning or sintering processes

Abstract

The present invention relates to: a core-shell structured metal-organic framework-polymer fiber-based adsorbent, which has excellent maximum adsorption capacity and adsorption rate characteristics with respect to rare earth metals and allowing for easy adsorbent recovery; a preparation method therefor; and a rare earth metal recovery method using same. The core-shell structured metal-organic framework-polymer fiber-based adsorbent according to the present invention comprises a metal-organic framework on the surface of a sodium polyacrylate (NaPA) fiber.

IPC Classes  ?

• B01J 20/28 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof characterised by their form or physical properties
• B01J 20/22 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof comprising organic material
• B01J 20/32 - Impregnating or coating
• C22B 59/00 - Obtaining rare earth metals
• C22B 7/00 - Working-up raw materials other than ores, e.g. scrap, to produce non-ferrous metals or compounds thereof

Abstract

The present invention relates to a metal-organic framework-polymer fiber-based adsorbent having a core-shell structure and a method for preparing the adsorbent, and a method for recovering a rare earth metal using the same, which result in having easy recovery of the adsorbent together with excellent characteristics of a maximum adsorption amount and an adsorption rate for the rare earth metal. The metal-organic framework-polymer fiber-based adsorbent having the core-shell structure according to the present invention is characterized in that the metal-organic framework is provided on a surface of a sodium polyacrylate (NaPA) fiber.

IPC Classes  ?

• B01J 20/22 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof comprising organic material
• B01D 15/08 - Selective adsorption, e.g. chromatography
• B01J 20/28 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof characterised by their form or physical properties

Abstract

The present disclosure relates to an apparatus and a method for generating an image, which may generate a new viewpoint image using few-shot 2D images and is characterized by extracting and learning albedo representing intrinsic color information from the few-show 2D input images, intrinsically decomposing a color value synthesized in the form of patch from a new viewpoint using the few-shot 2D input images and extracting patch-wise albedo during learning, perform geometric alignment necessary for pixel correspondence between a new viewpoint image and a selected 2D input image using a depth value synthesized in the form of patch from the new viewpoint, and generating the new viewpoint image by calculating an albedo consistency loss between the patch-wise albedo.

IPC Classes  ?

• G06T 15/20 - Perspective computation
• G06T 7/30 - Determination of transform parameters for the alignment of images, i.e. image registration
• G06T 7/90 - Determination of colour characteristics
• G06T 15/50 - Lighting effects

Abstract

The present disclosure relates to an apparatus for synthesizing a 2D image and media using a reverse rendering including 3D spatially varying lighting information estimation, and the apparatus includes a target view analysis unit configured to estimate a normal map and direct lighting using a plurality of 2D images, a material estimation unit configured to reflect the normal map and direct lighting estimated from the target view analysis unit and estimate material information, a 3D lighting estimation unit configured to reflect the direct lighting estimated from the target view analysis unit and the material information estimated from the material estimation unit and estimate 3D spatially varying lighting information, and an image generation unit configured to reflect the estimated shapes, materials, and 3D spatially varying lighting information, synthesize the 2D images with 3D objects, and generate a synthesized image.

IPC Classes  ?

• G06T 15/20 - Perspective computation
• G06T 15/50 - Lighting effects

Abstract

The present disclosure relates to relates to a assistive wearable system for relieving muscle fatigue in the neck and shoulders, the assistive wearable system includes a head gear mounted to cover a head of a user, a wearable platform mounted on an upper body of the user, and a wire tension controller that maintains tension of a wire by being seated on the wearable platform and fixing to operate a semi-active ratchet mechanism structure as a brake to detect a moment a movement of the wire stops as connected to the head gear by the wire, and stop unwinding of the wire, wherein the ratchet mechanism rotates the ratchet based on the unwinding and pulling of the wire.

IPC Classes  ?

• A61F 5/02 - Orthopaedic corsets

Abstract

The present invention relates to a nanostructure and use thereof, the nanostructure comprising: a polymer material having a cyclodextrin-derived functional group chemically bonded thereto; and a guest material where a first moiety with a molecular diameter larger than 4.7 Å and a second moiety with a molecular diameter smaller than 4.7 Å are bonded to each other.

IPC Classes  ?

• C08B 37/16 - CyclodextrinDerivatives thereof
• A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit

Abstract

The present disclosure relates to a gripper and grippers capable of being easily combined to safely grip and transfer objects with various and complicated shapes. In order to achieve the above-mentioned object, the technical aspects of the present disclosure provides a gripper including a variable loop having one end fixed to a transfer means and configured to surround and grip an object while being curved in a closed shape by air introduced into an air chamber in the variable loop, and a locking means configured to lock the variable loop when the variable loop is curved in a closed shape to maintain the closed shape.

IPC Classes  ?

• B25J 15/00 - Gripping heads
• B25J 15/06 - Gripping heads with vacuum or magnetic holding means
• B25J 15/12 - Gripping heads having finger members with flexible finger members

Abstract

The present invention relates to quinolinone derivatives or pharmaceutically acceptable salt thereof, a composition for preventing or treating cancer comprising the derivatives as an active ingredient, and the like, the quinolinone derivative of the present invention being highly effective in inhibiting ENPP1 activity. Therefore, the present invention can be used for the purpose of treating, preventing, and alleviating cancerous diseases caused by abnormal cell growth. In addition, the quinolinone derivatives and pharmaceutically acceptable salt thereof of the present invention effectively inhibit ENPP1 to activate the STING pathway, and thus can be effectively used in preventing or treating cancer.

IPC Classes  ?

• C07D 215/227 - Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
• A61K 31/4704 - 2-Quinolinones, e.g. carbostyril
• A61P 35/00 - Antineoplastic agents
• C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
• C07D 471/10 - Spiro-condensed systems
• C07D 487/10 - Spiro-condensed systems

Abstract

The present invention relates to pyrimidooxazinone derivatives or pharmaceutically acceptable salt thereof, a composition for preventing or treating cancer comprising the derivative as an active ingredient, and the like, the pyrimidooxazinone derivatives of the present invention being highly effective in inhibiting ENPP1 activity. Therefore, the present invention can be used for the purpose of treating, preventing, and alleviating cancerous diseases caused by abnormal cell growth. In addition, the pyrimidooxazinone derivatives and pharmaceutically acceptable salt thereof of the present invention effectively inhibit ENPP1 to activate the STING pathway, and thus can be effectively used in preventing or treating cancer.

IPC Classes  ?

• C07D 498/04 - Ortho-condensed systems
• A61K 31/55 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
• A61K 31/551 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep
• A61K 31/5383 - 1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
• A61P 35/00 - Antineoplastic agents

Abstract

A light-sensing device senses incident light of a predetermined wavelength and includes a photodiode substrate having a P-N junction structure and a first surface and a second surface facing each other; a metal layer formed on the first surface of the photodiode substrate; and a functional layer formed on the metal layer, and increasing an absorption rate of the metal layer with respect to light of the predetermined wavelength.

IPC Classes  ?

• H01L 27/146 - Imager structures
• G01S 7/481 - Constructional features, e.g. arrangements of optical elements

Abstract

The present application relates to an apparatus and method for evaluating XR-based upper limb motion control and motion control ability, the apparatus including a head mount display (HMD) configured to be worn on a user's head part and including a display for providing visual feedback information capable of monitoring a visual cue and a repetitive motion of muscle synergy or a direction and magnitude of a force that are contents for XR (eXtended Reality)-based multi-joint rehabilitation training of an upper limb, a measurement part, a synergy evaluation part, a visual cue control part and a composite biofeedback part.

IPC Classes  ?

• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• A63B 23/12 - Exercising apparatus specially adapted for particular parts of the body for limbs, i.e. upper or lower limbs, e.g. simultaneously for upper limbs
• G02B 27/01 - Head-up displays
• G06F 3/01 - Input arrangements or combined input and output arrangements for interaction between user and computer
• G06T 19/00 - Manipulating 3D models or images for computer graphics

Abstract

The present invention relates to hydrogen peroxide manufacturing process and manufacturing system based on a photochemical reaction. Specifically, the present invention relates to a series of hydrogen peroxide manufacturing processes of generating, extracting, and purifying hydrogen peroxide through a photochemical reaction, and a hydrogen peroxide manufacturing system which is applied with the manufacturing processes and consists of a photoreactor-extractor-purifier.

IPC Classes  ?

• C01B 15/026 - Preparation from organic compounds from alcohols
• B01J 31/06 - Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing polymers
• B01J 31/40 - Regeneration or reactivation
• B01J 35/39 - Photocatalytic properties
• C01B 15/013 - SeparationPurificationConcentration

Abstract

The present invention relates to a method for area-selective growth of a noble metal thin film using atomic layer deposition, which can increase the growth thickness of a thin film with a high selectivity by inducing the generation of volatile noble metal oxides and suppressing the growth of the thin film in non-growth areas in depositing a noble metal thin film on the growth area of a substrate using nucleation delay.

IPC Classes  ?

• C23C 16/04 - Coating on selected surface areas, e.g. using masks
• C23C 16/06 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of metallic material

Abstract

The present invention provides a solid oxide fuel cell including a fuel electrode support including Ni-YSZ; a functional layer positioned on the fuel electrode support; an electrolyte layer positioned on the functional layer; an interlayer positioned on the electrolyte layer; and an air electrode layer positioned on the interlayer, wherein the functional layer includes gadolinium-doped ceria (GDC) nanoparticles dispersed.

IPC Classes  ?

• H01M 8/1213 - Fuel cells with solid electrolytes operating at high temperature, e.g. with stabilised ZrO2 electrolyte characterised by the electrode/electrolyte combination or the supporting material
• H01M 4/88 - Processes of manufacture
• H01M 4/90 - Selection of catalytic material
• H01M 8/12 - Fuel cells with solid electrolytes operating at high temperature, e.g. with stabilised ZrO2 electrolyte
• H01M 8/1253 - Fuel cells with solid electrolytes operating at high temperature, e.g. with stabilised ZrO2 electrolyte characterised by the process of manufacturing or by the material of the electrolyte the electrolyte consisting of oxides the electrolyte containing zirconium oxide

Abstract

Proposed are a flow-through reactor for conversion of carbon dioxide and a method for conversion of carbon dioxide using the flow-through reactor. Carbon dioxide and a catholyte are separately supplied, and a reference electrode having a large volume is capable of being mounted on an electrolyte pocket without increasing resistance since a structure of the electrolyte pocket is improved.

IPC Classes  ?

• C25B 3/26 - Reduction of carbon dioxide
• C25B 9/15 - Flow-through cells
• C25B 9/23 - Cells comprising dimensionally-stable non-movable electrodesAssemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded
• C25B 15/08 - Supplying or removing reactants or electrolytesRegeneration of electrolytes

Abstract

The method comprises separating the outer green rind the room aloe vera leaf thereby cleaning and drying in sunlight for two days followed by oven drying at 80° C. for about 24 hours; pyrolyzing the dried outer green rind in an inert environment of N2 gas at 400° C. for about 1 hour to obtain a pre-carbonized carbon (AV-C); mixing the AV-C with K2CO3 in a 2:1 impregnation ratio to obtain a mixture;; pyrolyzing the mixture of the AV-C and K2CO3 at 900° C.; removing resulting black charred residue and cleaning the resulting charred residue with double-distilled water and isopropyl alcohol; homogenizing the cleaned black material of reduced graphene oxide using an ultrasonic homogenizer at 30% power for 1 hour with 10 pulse rates thereby drying and filtering the reduced graphene oxide to obtain 3D-HPN-rGO; h) preparing an electrode using the obtained 3D-HPN-rGO; and i) constructing a supercapacitor device using the electrodes.

IPC Classes  ?

• H01G 11/44 - Raw materials therefor, e.g. resins or coal
• C01B 32/198 - Graphene oxide
• C01B 32/21 - After-treatment
• H01G 11/86 - Processes for the manufacture of hybrid or EDL capacitors, or components thereof specially adapted for electrodes

Abstract

According to a method and device for generating a head avatar using a shot video, a head mesh of neutral look and a head texture map of neutral look are generated based on a base mesh of a base model and at least one shooting image representing a face of neutral look among a plurality of shooting images generated from a camera shot video, and a head mesh reflecting a certain facial expression and a head texture reflecting the certain facial expression are generated based on at least one shooting image representing a face of a certain facial expression among the plurality of shooting images, the head mesh of neutral look, and the head texture map of neutral look.

IPC Classes  ?

• G06T 19/20 - Editing of 3D images, e.g. changing shapes or colours, aligning objects or positioning parts
• G06T 15/04 - Texture mapping
• G06T 17/20 - Wire-frame description, e.g. polygonalisation or tessellation

Abstract

An apatite for a filler includes an apatite that contains metal. The metal entirely or partially replaces the calcium of the apatite. A filler composition includes the apatite and hyaluronic acid. The metal may be magnesium (Mg), zinc (Zn), and/or strontium (Sr). The metal of the apatite replaces the calcium of the apatite in a solution using a laser.

IPC Classes  ?

• A61K 6/838 - Phosphorus compounds, e.g. apatite
• A61K 6/84 - Preparations for artificial teeth, for filling teeth or for capping teeth comprising metals or alloys
• A61K 6/898 - Polysaccharides
• C01B 25/32 - Phosphates of magnesium, calcium, strontium, or barium
• C01B 25/34 - Magnesium phosphates
• C01B 25/37 - Phosphates of heavy metals
• C01B 25/45 - Phosphates containing plural metal, or metal and ammonium

Abstract

The present application relates to an ultrasound image generation device using the nonlinearity of ultrasonic waves, the device comprising: an ultrasound probe for outputting an ultrasonic signal to a region of interest and receiving the ultrasonic signal reflected from the region of interest; and an image generation unit for generating an ultrasound image from the ultrasonic signal received by the ultrasound probe. The ultrasound probe comprises: an ultrasonic wave output unit having a plurality of transducers annularly arranged at regular intervals so as to output, toward the region of interest, a first ultrasonic signal associated with a first frequency, or a second ultrasonic signal associated with a second frequency different from the first frequency; and an ultrasonic wave receiving unit for generating a third ultrasonic signal by using the nonlinearity of the first frequency and the second frequency at a focal point where the first ultrasonic signal and the second ultrasonic signal cross each other, and receiving the third ultrasonic signal reflected from the region of interest.

IPC Classes  ?

• A61B 8/00 - Diagnosis using ultrasonic, sonic or infrasonic waves
• A61B 8/08 - Clinical applications

Abstract

The present invention relates to lipid nanoparticles carrying a material for detecting target nucleic acids, and a use thereof.

IPC Classes  ?

• C12Q 1/6816 - Hybridisation assays characterised by the detection means
• C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Abstract

The present invention relates to a composition for preventing, alleviating, or treating ischemic cerebrovascular disease and sequelae thereof. A composition comprising an aminoaromatic compound according to one aspect has an effect of significantly reducing the size of physical wounds and infarctions in the brain due to ischemic cerebrovascular disease, thereby having an effect of enabling recovery from sequelae due to ischemic cerebrovascular disease.

IPC Classes  ?

• A61K 31/136 - Amines, e.g. amantadine having aromatic rings, e.g. methadone having the amino group directly attached to the aromatic ring, e.g. benzeneamine
• A61P 9/00 - Drugs for disorders of the cardiovascular system
• A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives

Abstract

Disclosed herein is a metamaterial sensing platform. The metamaterial sensing platform includes: a sensing portion configured to capture a particle; and a terahertz sensor portion configured to sense the particle by allowing a terahertz electromagnetic wave to be incident on the sensing portion; wherein the sensing portion includes a base substrate and a particle capture portion disposed on the base substrate and having a plurality of slits formed therein through which the particle is captured, and wherein a nanodisk reactive with the particle is disposed in the plurality of slits.

IPC Classes  ?

• G01N 33/50 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing
• G01N 33/531 - Production of immunochemical test materials
• G01N 33/68 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving proteins, peptides or amino acids
• G02B 1/00 - Optical elements characterised by the material of which they are madeOptical coatings for optical elements

Abstract

The present disclosure discloses a catalyst for liquid phase reforming of biomass derived from hydrotalcite, a method for preparing the same, and a method for producing hydrogen using the same. The catalyst is a mixed metal oxide catalyst, the catalyst is a nickel-zinc-aluminum mixed metal oxide of a hydrotalcite structure, and the catalyst is used for liquid phase reforming of biomass. The catalyst has an effect of providing a high yield of hydrogen by improving an efficiency of the liquid phase reforming reaction of biomass.

IPC Classes  ?

• B01J 23/00 - Catalysts comprising metals or metal oxides or hydroxides, not provided for in group
• B01J 23/80 - Catalysts comprising metals or metal oxides or hydroxides, not provided for in group of the iron group metals or copper combined with metals, oxides or hydroxides provided for in groups with zinc, cadmium or mercury
• B01J 37/03 - PrecipitationCo-precipitation
• B01J 37/06 - Washing
• B01J 37/08 - Heat treatment
• B01J 37/18 - Reducing with gases containing free hydrogen
• C01B 3/12 - Production of hydrogen or of gaseous mixtures containing hydrogen by reaction of inorganic compounds containing electro-positively bound hydrogen, e.g. water, acids, bases, ammonia, with inorganic reducing agents by reaction of water vapour with carbon monoxide
• C01B 3/32 - Production of hydrogen or of gaseous mixtures containing hydrogen by reaction of gaseous or liquid organic compounds with gasifying agents, e.g. water, carbon dioxide, air

Abstract

The present invention relates to a metamaterial sensing platform comprising: a sensing unit for collecting particles; and a terahertz sensor unit for sensing the particles by allowing terahertz electromagnetic waves to be incident on the sensing unit; wherein the sensing unit includes a base substrate and a particle collection unit disposed on the base substrate and having a plurality of slits in which the particles are collected, and nanodisks reacting with the particles are disposed in the plurality of slits.

IPC Classes  ?

• G01N 15/0205 - Investigating particle size or size distribution by optical means
• G01N 21/3586 - Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using far infrared lightInvestigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using Terahertz radiation by Terahertz time domain spectroscopy [THz-TDS]
• G01N 33/543 - ImmunoassayBiospecific binding assayMaterials therefor with an insoluble carrier for immobilising immunochemicals
• G02B 1/00 - Optical elements characterised by the material of which they are madeOptical coatings for optical elements

Abstract

The present invention relates to a novel compound derived from Myristica fragrans and to an anticancer composition comprising same. In the present invention, various novel compounds derived from Myristica fragrans extracts were isolated, and it was confirmed that most of the novel compounds exhibit cytotoxic effects against various cancer cell lines. It was confirmed that five compounds (3, 4, 6, 9, 11) exhibit high cytotoxic effects in gastric cancer and colorectal cancer. In particular, it was confirmed that the compound represented by chemical formula 3 effectively induces apoptosis by regulating the cell cycle of cancer cells, as well as effectively suppresses tumor growth in a xenograft mouse model, and thus can be effectively utilized as an anticancer composition.

IPC Classes  ?

• C07C 49/84 - Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
• C07D 317/50 - Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
• C07D 307/80 - Radicals substituted by oxygen atoms
• A61K 31/12 - Ketones
• A61K 31/36 - Compounds containing methylenedioxyphenyl groups, e.g. sesamin
• A61K 31/343 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
• A61K 36/185 - Magnoliopsida (dicotyledons)
• A61P 35/00 - Antineoplastic agents
• A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
• A23L 33/105F0 -

Abstract

A method of regenerating sodium borohydride includes: pretreating reactants including sodium tetraborate hydrate (Na2B4O7·xH2O, 0

IPC Classes  ?

• C01B 6/21 - Preparation of borohydrides of alkali metals, alkaline earth metals, magnesium or berylliumAddition complexes thereof, e.g. LiBH4.2N2H4, NaB2H7

Abstract

The present invention relates to a heteroaryl derivative, a stereoisomer thereof, a hydrate thereof, a solvate thereof, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition for preventing or treating cancer comprising the same as an active ingredient. The heteroaryl derivative of the present invention exhibits high inhibitory activity against overexpressed HER2, and thus, a pharmaceutical composition containing the same as an active ingredient can be usefully used for preventing or treating HER-2 positive cancer.

IPC Classes  ?

• C07D 473/34 - Nitrogen atom attached in position 6, e.g. adenine
• A61K 31/52 - Purines, e.g. adenine
• A61K 31/5377 - 1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
• A61P 35/00 - Antineoplastic agents
• C07D 473/16 - Heterocyclic compounds containing purine ring systems with oxygen, sulfur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
• C07D 473/40 - Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Abstract

Provided is a method for preventing, ameliorating, or treating inflammatory diseases by administering a composition containing extracellular vesicles (EVs) derived from Roseburia spp. strains and/or Bifidobacterium spp. strains, wherein the EVs exhibits effectiveness in improving inflammatory bowel disease (IBD), and additionally, all EVs derived from congeneric strains corresponding to Roseburia spp. strains or Bifidobacterium spp. strains. have been confirmed to exhibit strong anti-inflammatory effect, and the strains and EVs derived therefrom can be provided as a composition for preventing, ameliorating, or treating a variety of inflammatory diseases.

IPC Classes  ?

• A61K 9/50 - Microcapsules
• A61K 35/74 - Bacteria
• A61K 35/745 - Bifidobacteria
• A61P 37/06 - Immunosuppressants, e.g. drugs for graft rejection

Abstract

Disclosed herein is a method of manufacturing a dehydrogenation catalyst, the method includes: forming a functional oxide coating layer on a surface of a support with a first atomic layer deposition; and depositing metal particles on the surface of the support on which the functional oxide coating layer is formed, with a second atomic layer deposition.

IPC Classes  ?

• C23C 16/455 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating characterised by the method used for introducing gases into the reaction chamber or for modifying gas flows in the reaction chamber
• B01J 21/04 - Alumina
• B01J 21/06 - Silicon, titanium, zirconium or hafniumOxides or hydroxides thereof
• B01J 23/46 - Ruthenium, rhodium, osmium or iridium
• B01J 37/02 - Impregnation, coating or precipitation
• B01J 37/16 - Reducing
• C23C 16/40 - Oxides
• C23C 16/56 - After-treatment

Abstract

Disclosed in the present application are: lipid nanoparticles comprising a tumor-targeting ligand; a method for preparing same; and a pharmaceutical composition for preventing or treating tumors, comprising same. The lipid nanoparticles include a nucleic acid, an ionizable lipid, a phospholipid, a sterol, a first conjugate, and a second conjugate in which a tumor-targeting ligand is linked. The first conjugate is a conjugate of a phospholipid and a polymer, and the second conjugate is a conjugate in which a tumor-targeting ligands is linked to the first conjugate. The lipid nanoparticles have a high targeting ability to solid tumors expressing PD-L1.

IPC Classes  ?

• A61K 9/51 - Nanocapsules
• A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
• A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
• A61P 35/00 - Antineoplastic agents

Abstract

The present invention relates to a composition for predicting cetuximab responsiveness in cancer, and more specifically to a composition for predicting cetuximab responsiveness, comprising a complex (Cetux-probe) having a fluorophore and a quencher bound to both sides of a peptide cleaved by a lysosomal enzyme, and having cetuximab conjugated to the C-terminus of the peptide. The Cetux-probe of the present invention operates in the same manner as the therapeutic mechanism of cetuximab, and thus the therapeutic effect and responsiveness of cetuximab may be quickly and accurately predicted. Cetux-probe activated fluorescence may be used to measure EGFR degradation, and a strong linear correlation between the Cetux-probe activated fluorescence and the cytotoxicity of cetuximab was observed in colorectal cancer cells and tumor-bearing mice. In addition, the predictive ability of the Cetux-probe activated fluorescence was confirmed to be much higher than that of EGFR expression or KRAS mutation status, and thus the Cetux-probe of the present invention may be usefully employed for predicting a response to cetuximab therapy by assessing EGFR degradation.

IPC Classes  ?

• G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer
• C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Abstract

A catalyst electrode for production of 2,5-furandicarboxylic acid according to an embodiment of the present invention includes: a first metal substrate; and a second metal hydroxide coating layer located on a surface of the first metal substrate, wherein the first metal substrate includes one or more micro-sized first metal particles on the surface thereof, and the second metal hydroxide coating layer may be located on a surface of the first metal particles.

IPC Classes  ?

• C25B 11/061 - Metal or alloy
• C25B 3/05 - Heterocyclic compounds
• C25B 3/07 - Oxygen containing compounds
• C25B 11/037 - Electrodes made of particles
• C25B 11/091 - Electrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of at least one catalytic element and at least one catalytic compoundElectrodes formed of electrocatalysts on a substrate or carrier characterised by the electrocatalysts material consisting of two or more catalytic elements or catalytic compounds

Abstract

The objective of the present invention is to provide a hybrid PERC solar cell and a manufacturing method therefor, and a tandem solar cell comprising same and a manufacturing method therefor, the hybrid PERC solar cell being suitable for a monolithic tandem solar cell in which a perovskite thin-film solar cell is stacked and bonded on a silicon solar cell. In order to accomplish the objective, the present invention comprises: a silicon wafer; a rear passivation layer formed on the rear surface of the silicon wafer; a front passivation layer formed on the front surface of the silicon wafer; an emitter layer formed on the front passivation layer; a TCO layer formed on the emitter layer; and a rear electrode layer formed under the rear passivation layer, and electrically connected to the silicon wafer through an opening.

IPC Classes  ?

• H01L 31/0725 - Multiple junction or tandem solar cells
• H01L 31/05 - Electrical interconnection means between PV cells inside the PV module, e.g. series connection of PV cells
• H01L 31/0224 - Electrodes
• H01L 31/18 - Processes or apparatus specially adapted for the manufacture or treatment of these devices or of parts thereof
• H10K 30/50 - Photovoltaic [PV] devices
• H10K 30/40 - Organic devices sensitive to infrared radiation, light, electromagnetic radiation of shorter wavelength or corpuscular radiation comprising a p-i-n structure, e.g. having a perovskite absorber between p-type and n-type charge transport layers
• H10K 30/15 - Sensitised wide-bandgap semiconductor devices, e.g. dye-sensitised TiO2
• H10K 85/50 - Organic perovskitesHybrid organic-inorganic perovskites [HOIP], e.g. CH3NH3PbI3
• H10K 39/15 - Organic photovoltaic [PV] modulesArrays of single organic PV cells comprising both organic PV cells and inorganic PV cells

Abstract

Provided is a steel reinforcement including an amount of 0.07 to 0.43 wt % of carbon (C), an amount of 0.5 to 2.0 wt % of manganese (Mn), an amount of 0.05 to 0.5 wt % of silicon (Si), an amount greater than 0 and less than or equal to 0.5 wt % of chromium (Cr), an amount greater than 0 and less than or equal to 4.5 wt % of copper (Cu), an amount greater than 0 and less than or equal to 0.003 wt % of boron (B), an amount greater than 0 and less than or equal to 0.25 wt % of vanadium (V), an amount greater than 0 and less than or equal to 0.012 wt % of nitrogen (N), an amount greater than 0 and less than or equal to 0.03 wt % of phosphorus (P), an amount greater than 0 and less than or equal to 0.03 wt % of sulfur(S), an amount of 0.01 to 0.5 wt % of the sum of one or more of nickel (Ni), niobium (Nb) and titanium (Ti), the balance of iron (Fe), and other inevitable impurities. A final microstructure includes ferrite, bainite, pearlite, retained austenite, and precipitates comprising copper.

IPC Classes  ?

• C22C 38/32 - Ferrous alloys, e.g. steel alloys containing chromium with boron
• C21D 8/02 - Modifying the physical properties by deformation combined with, or followed by, heat treatment during manufacturing of plates or strips
• C21D 8/06 - Modifying the physical properties by deformation combined with, or followed by, heat treatment during manufacturing of rods or wires
• C22C 38/00 - Ferrous alloys, e.g. steel alloys
• C22C 38/02 - Ferrous alloys, e.g. steel alloys containing silicon
• C22C 38/04 - Ferrous alloys, e.g. steel alloys containing manganese
• C22C 38/20 - Ferrous alloys, e.g. steel alloys containing chromium with copper
• C22C 38/24 - Ferrous alloys, e.g. steel alloys containing chromium with vanadium
• C22C 38/26 - Ferrous alloys, e.g. steel alloys containing chromium with niobium or tantalum
• C22C 38/28 - Ferrous alloys, e.g. steel alloys containing chromium with titanium or zirconium
• C22C 38/40 - Ferrous alloys, e.g. steel alloys containing chromium with nickel

Abstract

Disclosed are a light-based diagnostic and therapeutic device and an operating method for the light-based diagnostic and therapeutic device. The operating method for the light-based diagnostic and therapeutic device may comprise the operations of: acquiring local images over time through a camera of the light-based diagnostic and therapeutic device; extracting image feature points from the local images; generating a lesion map including a lesion area of a user by combining the local images on the basis of the extracted image feature points; and generating a cumulative light irradiation map indicating cumulative information of therapeutic light output to the lesion area on the basis of the lesion map and position information of a light stimulation unit of the light-based diagnostic and therapeutic device over time.

IPC Classes  ?

• A61N 5/06 - Radiation therapy using light
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons

Abstract

The present invention relates to a compound sensing clathrin-mediated endocytosis, a fluorescent probe comprising same, and a sensor and a sensing method. The compound according to the present invention forms a micelle in a quenching state, and when in contact with a cell, the compound is transported into the cell through clathrin-mediated endocytosis and becomes fluorescent. Accordingly, the compound can be used to sense clathrin-mediated endocytosis or stain and label cells in which clathrin-mediated endocytosis takes place. The compound used in the present invention is particularly excellent in that the compound is stably transported via endocytosis into cells, such as live neurons or embryonic stem cells, within a relatively short time and maintains fluorescence for a long time at high fluorescence intensity. In addition, not only somatic cells but also cell-membranes and spikes can be stained.

IPC Classes  ?

• G01N 33/533 - Production of labelled immunochemicals with fluorescent label
• G01N 33/50 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing
• C09K 11/06 - Luminescent, e.g. electroluminescent, chemiluminescent, materials containing organic luminescent materials

Abstract

The present invention relates to a transparent anode active material having excellent light transmittance and electrical conductivity characteristics and a manufacturing method thereof, and a lithium ion battery and an all-solid-state lithium thin-film battery based on the same and having excellent charge/discharge capacity and charge/discharge rate, wherein the transparent anode active material according to the present invention is characterized by comprising a material of the following Chemical Formula 1: AgxSiOyN wherein x is 0

IPC Classes  ?

• H01M 4/58 - Selection of substances as active materials, active masses, active liquids of inorganic compounds other than oxides or hydroxides, e.g. sulfides, selenides, tellurides, halogenides or LiCoFySelection of substances as active materials, active masses, active liquids of polyanionic structures, e.g. phosphates, silicates or borates
• C01B 21/082 - Compounds containing nitrogen and non-metals
• H01M 4/02 - Electrodes composed of, or comprising, active material
• H01M 10/0525 - Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodesLithium-ion batteries

Abstract

A light-based diagnostic treatment apparatus and an operating method of a light-based diagnostic treatment apparatus are provided. The operating method of a light-based diagnostic treatment apparatus includes obtaining local images over time through a camera of the light-based diagnostic treatment apparatus, extracting an image feature point from the local images, generating a lesion map including a lesion area of a user by combining the local images based on the extracted image feature point, and generating a cumulative light irradiation map indicating accumulation information of therapeutic light output to the lesion area based on the lesion map and position information of an optical stimulation unit of the light-based diagnostic treatment apparatus.

IPC Classes  ?

• A61N 5/06 - Radiation therapy using light
• G06T 7/00 - Image analysis

Abstract

The present disclosure relates to a network polymer and a manufacturing method thereof. An object of one aspect of the present invention is to provide a network polymer that can recover and recycle a key monomer from a polymer with excellent decomposability and is formed therefrom to have excellent mechanical and electrical properties, and a method of manufacturing the same. The network polymer according to one embodiment of the present invention is recycled from a polymer with excellent decomposability and thus is eco-friendly, and exhibits the effect of having excellent mechanical and electrical properties.

IPC Classes  ?

• C08J 11/20 - Recovery or working-up of waste materials of polymers by chemically breaking down the molecular chains of polymers or breaking of crosslinks, e.g. devulcanisation by treatment with organic material by treatment with hydrocarbons or halogenated hydrocarbons
• C08J 11/14 - Recovery or working-up of waste materials of polymers by chemically breaking down the molecular chains of polymers or breaking of crosslinks, e.g. devulcanisation by treatment with steam or water
• H01L 31/072 - SEMICONDUCTOR DEVICES NOT COVERED BY CLASS - Details thereof adapted as photovoltaic [PV] conversion devices characterised by at least one potential-jump barrier or surface barrier the potential barriers being only of the PN heterojunction type
• H10K 30/30 - Organic devices sensitive to infrared radiation, light, electromagnetic radiation of shorter wavelength or corpuscular radiation comprising bulk heterojunctions, e.g. interpenetrating networks of donor and acceptor material domains

Abstract

The present invention relates to a pre-lithiation method for a silicon-based active material, and a silicon-based active material pre-lithiated thereby, the method comprising the steps of: (S1) immersing a silicon-based active material in a pre-lithiation solution comprising an organic solvent and a lithium-hydrocarbon molecular complex; (S2) washing same with the solvent and drying same, thereby obtaining a powder; and (S3) heat-treating the powder at a temperature of 400-800°C under an inert gas atmosphere.

IPC Classes  ?

• C01B 33/32 - Alkali metal silicates
• C01B 33/02 - Silicon
• H01M 4/36 - Selection of substances as active materials, active masses, active liquids
• H01M 4/58 - Selection of substances as active materials, active masses, active liquids of inorganic compounds other than oxides or hydroxides, e.g. sulfides, selenides, tellurides, halogenides or LiCoFySelection of substances as active materials, active masses, active liquids of polyanionic structures, e.g. phosphates, silicates or borates
• H01M 4/38 - Selection of substances as active materials, active masses, active liquids of elements or alloys
• H01M 4/583 - Carbonaceous material, e.g. graphite-intercalation compounds or CFx
• H01M 4/133 - Electrodes based on carbonaceous material, e.g. graphite-intercalation compounds or CFx
• H01M 4/134 - Electrodes based on metals, Si or alloys
• H01M 4/136 - Electrodes based on inorganic compounds other than oxides or hydroxides, e.g. sulfides, selenides, tellurides, halogenides or LiCoFy
• H01M 10/052 - Li-accumulators

Abstract

The present invention provides a linker having a net or cage structure, the structure of which is modified by a biomarker operating under a biphasic system consisting of a water layer and an oil layer. The linker is structurally modified in the presence of a biomarker to release a phase-shift probe contained therein, and the released phase-shift probe can be detected in the oil layer. In detection of the biomarker under the biphasic system using the linker of the present invention, the recognition of a target and the detection of a signal by the recognition are separated into the water layer and the oil layer, and thus the target can be detected with high accuracy. In addition, the system of the present invention does not require pretreatment of a sample, and thus can rapidly and accurately detect a quantitative biomarker with high sensitivity without expensive equipment and expertise required for pretreatment of a clinical specimen.

IPC Classes  ?

• C12Q 1/34 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving hydrolase
• G01N 21/84 - Systems specially adapted for particular applications

Abstract

Provided are a prelithiation method of a silicon-based active material, the prelithiation method including step S1 of immersing the silicon-based active material in a prelithiation solution including an organic solvent and a lithium-hydrocarbon molecule complex, step S2 of obtaining a powder by washing the silicon-based active material with the organic solvent and drying the silicon-based active material, and step S3 of performing a heat treatment on the powder at a temperature of 400° C. to 800° C. in an inert gas atmosphere, and a silicon-based active material prelithiated by the method.

IPC Classes  ?

• H01M 4/04 - Processes of manufacture in general
• H01M 4/02 - Electrodes composed of, or comprising, active material
• H01M 4/485 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of mixed oxides or hydroxides for inserting or intercalating light metals, e.g. LiTi2O4 or LiTi2OxFy
• H01M 4/62 - Selection of inactive substances as ingredients for active masses, e.g. binders, fillers

Abstract

Provided is a polydopamine composite material according to the concept of the present invention, wherein the polydopamine composite material includes a substrate with first nano-protrusions formed on a surface thereof, and a polydopamine layer on the surface of the substrate. The polydopamine layer includes second nano-protrusions protruding in a direction perpendicular to the surface of the substrate.

IPC Classes  ?

• C09D 179/04 - Polycondensates having nitrogen-containing heterocyclic rings in the main chainPolyhydrazidesPolyamide acids or similar polyimide precursors

Abstract

Provided is a fiber composite structure including a plurality of twisted fiber bundles, wherein each of the fiber bundles includes a plurality of fiber strands, an adhesive coated on the fiber strands, and a functional particle interposed between the fiber strands. The functional particle includes a material different from that of the fiber strands. The adhesive includes polydopamine.

IPC Classes  ?

• D02G 3/36 - Cored or coated yarns or threads
• D02G 3/02 - Yarns or threads characterised by the material or by the materials from which they are made
• D02G 3/40 - Yarns in which fibres are united by adhesivesImpregnated yarns or threads
• D06M 15/05 - Cellulose or derivatives thereof
• D06M 15/61 - Polyamines
• D06M 101/06 - Vegetal fibres cellulosic
• D06M 101/32 - Polyesters

Abstract

The present disclosure describes to a method embodiment for preparing a carbon nanotube composite that includes performing a first ultrasonic treatment on a first mixture containing a carbon nanotube (CNT) fiber and an acid to form a carbon nanotube fiber swollen body, and performing a second ultrasonic treatment on a second mixture containing the carbon nanotube fiber swollen body, an aromatic monomer, and an initiator to form a carbon nanotube composite including a surface coated with an aromatic monomer-derived conductive polymer, and an embodiment of the carbon nanotube composite prepared therefrom.

IPC Classes  ?

• C01B 32/174 - DerivatisationSolubilisationDispersion in solvents
• H01G 11/36 - Nanostructures, e.g. nanofibres, nanotubes or fullerenes

Abstract

A non-contact interface device for a vehicle and a method for controlling the same, may display an operation system menu for a driver and passengers to operate various kinds of devices of the vehicle as a hologram, enable a user to operate the displayed operation system menu in a non-contact manner by use of the user's finger or the like, and provide the user with a tactile feedback for a non-contact operation, so that the user can recognize whether to have operated the menu.

IPC Classes  ?

• B60K 35/00 - Instruments specially adapted for vehiclesArrangement of instruments in or on vehicles
• G06F 3/01 - Input arrangements or combined input and output arrangements for interaction between user and computer
• G06F 3/043 - Digitisers, e.g. for touch screens or touch pads, characterised by the transducing means using propagating acoustic waves
• G06F 3/0482 - Interaction with lists of selectable items, e.g. menus
• G06V 20/56 - Context or environment of the image exterior to a vehicle by using sensors mounted on the vehicle
• G06V 40/10 - Human or animal bodies, e.g. vehicle occupants or pedestriansBody parts, e.g. hands
• G06V 40/20 - Movements or behaviour, e.g. gesture recognition

Abstract

Provided is a method of manufacturing a stretchable substrate having improved thickness deformation uniformity through control of a spatial crosslinking degree according to various embodiments of the present disclosure to implement the above object. The method includes forming a substrate part of an elastic material, forming an auxetic including a plurality of unit structures on the substrate part, and forming a fixing part on the substrate part on which the auxetic is formed, wherein the fixing part has a different vertical crosslinking density at each position.

IPC Classes  ?

• B32B 3/12 - Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shapeLayered products comprising a layer having particular features of form characterised by a discontinuous layer, i.e. apertured or formed of separate pieces of material characterised by a layer of regularly-arranged cells whether integral or formed individually or by conjunction of separate strips, e.g. honeycomb structure
• B32B 7/022 - Mechanical properties
• B32B 37/14 - Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers

Abstract

The present disclosure relates to a contact verification technology based on signal similarity, and an apparatus of contact verification receives and stores spatiotemporal signal information capable of specifying time and space from a plurality of user equipments (UEs), extract the spatiotemporal signal information of a specific user among the stored spatiotemporal signal information, configure the extracted spatiotemporal signal information of the specific user as reference spatiotemporal signal information, and compare similarity between the reference spatiotemporal signal information and the other stored spatiotemporal signal information, and determine whether or not there is contact between the specific user and another user based on the similarity.

IPC Classes  ?

• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• G16H 80/00 - ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Abstract

The present invention relates to: a heteroaryl derivative, a stereoisomer thereof, a hydrate thereof, a solvate thereof, or a pharmaceutically acceptable salt thereof; a method for preparing same; and a pharmaceutical composition containing same as an active ingredient for the prevention or treatment of cancer, wherein the heteroaryl derivative of the present invention can be usefully employed for the prevention or treatment of HER2-positive carcinoma.

IPC Classes  ?

• C07D 473/34 - Nitrogen atom attached in position 6, e.g. adenine
• A61K 31/52 - Purines, e.g. adenine
• A61P 35/00 - Antineoplastic agents

Abstract

Provided is a method of manufacturing a stretchable substrate having improved stretching deformation uniformity through control of a spatial crosslinking degree according to various embodiments of the present disclosure to implement the above object. The method includes forming a substrate part of an elastic material, forming an auxetic including a plurality of unit structures on the substrate part, and forming a fixing part on the substrate part on which the auxetic is formed, wherein the fixing part has a different crosslinking density in each region.

IPC Classes  ?

• B32B 3/12 - Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shapeLayered products comprising a layer having particular features of form characterised by a discontinuous layer, i.e. apertured or formed of separate pieces of material characterised by a layer of regularly-arranged cells whether integral or formed individually or by conjunction of separate strips, e.g. honeycomb structure
• B32B 7/022 - Mechanical properties
• B32B 37/14 - Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers

Abstract

The present invention relates to a technology for identifying a contact on the basis of a signal similarity. An apparatus for identifying a contact: receives space-time signal information capable of specifying time and space from a plurality of user terminals and stores the received space-time signal information; extracts space-time signal information of a specific user from the stored space-time signal information; configures the extracted space-time signal information of the specific user as reference space-time signal information; compares a similarity between the reference space-time signal information and the stored other space-time signal information; and determines whether the specific user and another user are in contact with each other on the basis of the similarity.

IPC Classes  ?

• G16H 50/80 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
• G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
• H04W 4/029 - Location-based management or tracking services
• H04W 4/80 - Services using short range communication, e.g. near-field communication [NFC], radio-frequency identification [RFID] or low energy communication
• H04W 84/12 - WLAN [Wireless Local Area Networks]

Abstract

The present disclosure relates to a multilayer reinforced composite electrolyte membrane and a method for manufacturing the same. The multilayer reinforced composite electrolyte membrane according to the present disclosure has sufficient mechanical properties and improved membrane resistance at the same time since a porous support is impregnated in an ionomer and it is stacked in a multilayer structure. Furthermore, since the composite electrolyte membrane has no wrinkles and cracks due to excellent dimensional stability, it can improve the electrochemical properties of batteries.

IPC Classes  ?

• C25B 13/08 - DiaphragmsSpacing elements characterised by the material based on organic materials
• C25B 13/02 - DiaphragmsSpacing elements characterised by shape or form

Abstract

Provided is BRCA-specific siRNA for enhancing the sensitivity of cancer cells to PARP inhibitors. According to the present disclosure, the siRNA can induce cancer cell death together with the PARP inhibitors in patients with wild-type BRCA genes with a low therapeutic effect of the PARP inhibitors, and the fusion protein-siRNA complex for siRNA delivery is up-taken into cells via CD47, and thus more specifically delivered to cancer cells while up-taken with high efficiency, thereby maximizing a desired cell death effect.

IPC Classes  ?

• C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
• A61K 47/65 - Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
• A61P 35/00 - Antineoplastic agents

Abstract

The present invention relates to a composition for improving intestinal health and function comprising: a milk-derived exosomes; and a therapeutic agent, wherein the therapeutic agent is DNA, RNA, or a small molecule, and the therapeutic agent is positioned and encapsulated in spaces inside the exosomes. In addition, provided is a method for manufacturing a composition for improving intestinal health and function, the method comprising the steps of: (a) isolating exosomes from milk; (b) forming micropores on the surfaces of the exosomes by subjecting the separated exosomes to electroporation; (c) mixing the exosomes that have undergone electroporation in step (b) with a therapeutic agent; and (d) removing therapeutic agent which has not been encapsulated inside the exosomes.

IPC Classes  ?

• A61K 9/19 - Particulate form, e.g. powders lyophilised
• A61K 9/50 - Microcapsules
• A61K 31/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
• A61K 31/711 - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
• A61K 31/713 - Double-stranded nucleic acids or oligonucleotides
• A61K 35/20 - MilkWheyColostrum

Abstract

An artificial intelligence system and a method for generating action tendency by considering emotion and mood according to recognition of external information include generating primary emotion and mood based on external information of the artificial intelligence system and a preset nature data, generating secondary emotion based on the generated mood, and generating action tendency for suggesting a direction of action decision of the artificial intelligence system based on the generated secondary emotion, and accordingly, an artificial intelligence system capable of smooth and natural interaction with people may be provided.

IPC Classes  ?

• G06N 5/022 - Knowledge engineeringKnowledge acquisition

Abstract

Disclosed herein are a catalyst for low-temperature carbon monoxide purification, a method for manufacturing the same, and a method for purifying carbon monoxide using the same. The catalyst comprises a metal oxide carrier; a transition metal oxide primarily supported on the carrier, and ruthenium secondarily supported on a carrier carrying the transition metal oxide. The catalyst provides an effect capable of purifying carbon monoxide contained in a hydrogen gas at a low temperature.

IPC Classes  ?

• B01J 21/06 - Silicon, titanium, zirconium or hafniumOxides or hydroxides thereof
• B01J 21/04 - Alumina
• B01J 23/00 - Catalysts comprising metals or metal oxides or hydroxides, not provided for in group
• B01J 23/46 - Ruthenium, rhodium, osmium or iridium
• C01B 3/58 - Separation of hydrogen or hydrogen containing gases from gaseous mixtures, e.g. purification by contacting with solidsRegeneration of used solids including a catalytic reaction

Abstract

A method of generating a drum play motion of a robot includes generating a plurality of rhythms of a melody, assigning each of a plurality of notes forming a rhythm of each part to one of the right hand and the left hand of the robot, scheduling swing time of each of the right hand and the left hand to which each note is assigned, and generating a trajectory of each of a plurality of joints of the robot for playing the rhythm of each part based on the swing time of each of the right hand and the left hand, and by controlling a motion of each of the plurality of joints according to the trajectory of each of the plurality of joints generated in this way, creative drum play of a humanoid robot may be done when only a melody is input.

IPC Classes  ?

• B25J 9/16 - Programme controls

Abstract

The present invention provides: a pharmaceutical composition for preventing or treating aging-related diseases or disorders, comprising an aminoaromatic compound or a pharmaceutically acceptable salt thereof as an active ingredient; a composition for delaying aging or extending lifespan; and a health functional food composition for preventing or alleviating aging-related diseases.

IPC Classes  ?

• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61P 17/18 - Antioxidants, e.g. antiradicals
• A61P 39/06 - Free radical scavengers or antioxidants

Abstract

The present invention relates to a novel saturated heterocycle-substituted heteroaryl-carbonohydrazonoyl dicyanide compound or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a pharmaceutical composition comprising same as an active ingredient for preventing or treating neurological diseases. The saturated heterocycle-substituted heteroaryl-carbonohydrazonoyl dicyanide compound of the present invention inhibits the aggregation or hyperphosphorylation of tau protein and/or TDP-43, and thus can be used for preventing and treating neurological diseases including tauopathy and TDP-43 proteinopathy.

IPC Classes  ?

• C07D 277/82 - Nitrogen atoms
• A61K 31/5377 - 1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
• A61K 31/5386 - 1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
• A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• C07D 263/58 - BenzoxazolesHydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
• C07D 235/30 - Nitrogen atoms not forming part of a nitro radical
• C07D 498/08 - Bridged systems
• C07D 413/04 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring- member bond
• C07D 471/04 - Ortho-condensed systems
• C07D 498/04 - Ortho-condensed systems

Abstract

The present invention relates to a composition for preventing or treating muscle disease comprising an extract of Aralia Elata. The Aralia Elata extract of the present invention has the effect of improving grip strength, increasing muscle weight, and improving exercise performance.

IPC Classes  ?

• A61K 36/25 - Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
• A61K 31/05 - Phenols
• A61K 31/085 - Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
• A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
• A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
• A61K 31/216 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
• A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
• A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
• A61P 43/00 - Drugs for specific purposes, not provided for in groups

Abstract

Provided is a modular experiment automation system including a main computer, a material synthesis module, and a material analysis module. The main computer interacts with a material synthesis module and a material analysis module. Upon a start request, it provides synthesis instructions for a target material. Once synthesis is complete, it instructs the analysis module to analyze the material. Based on the analysis results, if the error exceeds a threshold, it generates a new synthesis condition and re-initiates synthesis.

IPC Classes  ?

• G01N 35/00 - Automatic analysis not limited to methods or materials provided for in any single one of groups Handling materials therefor
• G06Q 10/0633 - Workflow analysis

Abstract

The present invention relates to: a fluorescent compound represented by formula 1 or a pharmaceutically acceptable salt thereof; and a composition for detecting gingipain, a composition for diagnosing Porphyromonas gingivalis infection, or an antibacterial composition against Porphyromonas gingivalis using same.

IPC Classes  ?

• C09K 11/06 - Luminescent, e.g. electroluminescent, chemiluminescent, materials containing organic luminescent materials
• A61K 31/41 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
• A61P 31/04 - Antibacterial agents
• G01N 33/569 - ImmunoassayBiospecific binding assayMaterials therefor for microorganisms, e.g. protozoa, bacteria, viruses
• G01N 33/533 - Production of labelled immunochemicals with fluorescent label
• G01N 21/64 - FluorescencePhosphorescence
• A01N 43/713 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with four or more nitrogen atoms as the only ring hetero atoms
• A01P 1/00 - DisinfectantsAntimicrobial compounds or mixtures thereof

Abstract

A device for monitoring a sleep state of a community mounted on each measurement target forming the community includes an electrode unit configured to measure biosignals including an electroencephalogram (EEG) and electromyography (EMG) of each measurement target forming the community, a control unit configured to compare the measured EEG and A device for monitoring a sleep state of a community mounted on each measurement target forming the community includes an electrode unit configured to measure biosignals including an electroencephalogram (EEG) and electromyography (EMG) of each measurement target forming the community, a control unit configured to compare the measured EEG and EMG with critical values and classify sleep and wake states of the measurement target, an indicating unit configured to emit light in different colors according to the sleep and wake states of the measurement target, and a recording and communication unit configured to store or transmit the measured EEG and EMG to an external device. Therefore, by measuring a sleeping behavior of each entity of the community and analyzing and visualizing the sleep and wake states in real time, it is possible to efficiently observe the interaction between sleep and an environment.

IPC Classes  ?

• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• A61B 5/369 - Electroencephalography [EEG]
• A61B 5/389 - Electromyography [EMG]

Abstract

Provided are a regeneration solution of a spent secondary battery cathode material, the regeneration solution including p-type redox molecules, a solvent, and a lithium salt, in which the p-type redox molecules have a reduction potential that is higher than or equal to 1.55 volt (V) and lower than or equal to 3.7 V with respect to a reduction potential (vs Li/Li+) of lithium, a method of regenerating a cathode material and a regenerated cathode material using this, and a method of recycling the regeneration solution.

IPC Classes  ?

• H01M 10/54 - Reclaiming serviceable parts of waste accumulators
• H01M 4/02 - Electrodes composed of, or comprising, active material
• H01M 4/04 - Processes of manufacture in general

Abstract

The present invention provides a BRCA-specific siRNA for the purpose of improving the sensitivity of cancer cells to a PARP inhibitor. The siRNA of the present invention can induce cancer cell death together with a PARP inhibitor in patients having a wild-type BRCA gene with low therapeutic efficacy of the PARP inhibitor. A fusion protein-siRNA complex for siRNA delivery, of the present invention, is introduced into cells via CD47, and thus can be delivered more specifically to cancer cells while being introduced with high efficiency, thereby maximizing a desired cell death effect.

IPC Classes  ?

• A61K 31/713 - Double-stranded nucleic acids or oligonucleotides
• A61K 31/502 - PyridazinesHydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
• A61K 31/5025 - PyridazinesHydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
• A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61P 35/00 - Antineoplastic agents
• C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Abstract

The present invention relates to an organic working solution for photochemical hydrogen peroxide production, and a method for producing hydrogen peroxide by photo-autoxidation utilizing the organic working solution. The present invention relates to an organic working solution for photochemical hydrogen peroxide production, and a method for producing hydrogen peroxide by photo-autoxidation utilizing the organic working solution. Specifically, the present invention relates to a method for producing hydrogen peroxide from an organic working solution in which oxidation of an aromatic alcohol and reduction of oxygen occur through photo-autoxidation of an aromatic carbonyl compound contained in the organic working solution, and the reduced oxygen.

IPC Classes  ?

• C01B 15/026 - Preparation from organic compounds from alcohols

Abstract

Disclosed in the present specification are a two-dimensional MXene surface-modified with a metal-organic network, a method of preparing the same, a MXene organic ink containing the same, and uses (e.g., an electromagnetic wave shielding material). In one aspect, the two-dimensional MXene surface-modified with a metal-organic network according to the present invention can use various organic ligands by linking the surface with the organic through the metal, and can be stably dispersed in various organic solvents, especially in industrial non-polar organic solvents as well as polar organic solvents, thereby being applied to a more general-purpose technologies, and securing stability against chemical oxidation to improve long-term stability.

IPC Classes  ?

• C09D 11/52 - Electrically conductive inks
• C01B 32/907 - OxycarbidesSulfocarbidesMixture of carbides
• C09D 11/033 - Printing inks characterised by features other than the chemical nature of the binder characterised by the solvent
• C09D 11/037 - Printing inks characterised by features other than the chemical nature of the binder characterised by the pigment
• H05K 9/00 - Screening of apparatus or components against electric or magnetic fields

Abstract

The present invention relates to a regeneration solution of a waste secondary battery cathode material, a method for regenerating a cathode material and a regenerated cathode material, using same, and a method for recycling the regeneration solution, the regeneration solution comprising p-type redox molecules, a solvent, and a lithium salt, wherein the reduction potential of the p-type redox molecules is 1.55-3.7 V versus lithium (vs Li/Li+).

IPC Classes  ?

• H01M 10/54 - Reclaiming serviceable parts of waste accumulators
• H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
• H01M 4/02 - Electrodes composed of, or comprising, active material

Abstract

The present invention relates to a core-shell typed composite filler including: a core including a thermosetting polymer resin; and a shell including a plurality of first nano/micro materials positioned on a surface of the core, and to a polymer composite material with the same applied. Further, the present invention also relates to a method of manufacturing a polymer composite material, the method includes: forming the core-shell typed composite filler; and dispersing the core-shell typed composite filler and the second nano/micro material into a polymer matrix.

IPC Classes  ?

• C08K 9/10 - Encapsulated ingredients

Abstract

The present invention relates to a composition for mimicking acupuncture treatment, comprising a Gq-DREADD expression vector administered to an acupoint as an active ingredient. The present invention provides a technique for mimicking acupuncture treatment by applying chemical genetics to an acupoint, thereby non-invasively enabling the expression of Gq-DREADD in neurons of an individual and the activation of the Gq-DREADD so as to enhance the cognitive and/or motor skills of the individual, and enabling the reduction of neuropathic pain and the alleviation of atopic dermatitis symptoms, and thus the present invention is expected to be used as a means for replacing acupuncture treatment in which the same result cannot be guaranteed depending on the operator.

IPC Classes  ?

• A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/55 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
• A61K 31/551 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep
• A61K 31/5513 - 1,4-Benzodiazepines, e.g. diazepam
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61P 25/00 - Drugs for disorders of the nervous system

Abstract

Disclosed are a patterned optical stimulation device and method. The patterned optical stimulation device according to one aspect includes: an imaging unit which generates a skin tissue image; a diagnosis unit which detects a region of interest from the skin tissue image and diagnoses the detected region of interest; and an optical stimulation unit which forms patterned treatment light corresponding to the region of interest and irradiates the region of interest with the formed patterned treatment light.

IPC Classes  ?

• A61N 5/06 - Radiation therapy using light
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons

Abstract

A spin Hall magnetic sensor includes a plurality of magnetic thin film units including a magnetic layer stacked on a non-magnetic layer, and a plurality of non-magnetic substances disposed between the plurality of magnetic thin film units, The magnetic includes a Wheatstone bridge structure to observe a magnetic Hall resistance generated by a spin orbit torque (SOT).

IPC Classes  ?

• G01R 33/07 - Hall-effect devices
• G01R 33/00 - Arrangements or instruments for measuring magnetic variables
• G01R 33/09 - Magneto-resistive devices

Abstract

The present invention includes: a porous structure containing an oxygen ion conductive material; and a coating layer disposed on the porous structure and containing an electronically conductive material, in which a content of the oxygen ion conductive material is greater than that of the electronically conductive material, and the coating layer is uniformly formed to a thickness of 20 nm or less.

IPC Classes  ?

• H01M 4/86 - Inert electrodes with catalytic activity, e.g. for fuel cells
• H01M 4/88 - Processes of manufacture
• H01M 4/90 - Selection of catalytic material
• H01M 8/10 - Fuel cells with solid electrolytes

Abstract

A bearing steel has improved insulation performance by forming a continuous insulating film. The bearing steel includes 0.65 to 1.0 mass % of carbon (C), 1.6 to 2.0 mass % of chromium (Cr), 1.5 to 3.0 mass % of aluminum (Al), 0.8 to 1.2 mass % of manganese (Mn), 0.7 to 1.0 mass % of silicon (Si), 0.1 to 0.3 mass % of nickel (Ni), 0.08 to 0.12 mass % of molybdenum (Mo), and a balance of iron (Fe), in which an oxynitride layer including a nitride layer and an oxide layer is formed on the surface of a material.

IPC Classes  ?

• C22C 38/44 - Ferrous alloys, e.g. steel alloys containing chromium with nickel with molybdenum or tungsten
• C21D 8/02 - Modifying the physical properties by deformation combined with, or followed by, heat treatment during manufacturing of plates or strips
• C22C 38/00 - Ferrous alloys, e.g. steel alloys
• C22C 38/02 - Ferrous alloys, e.g. steel alloys containing silicon
• C22C 38/04 - Ferrous alloys, e.g. steel alloys containing manganese
• C22C 38/06 - Ferrous alloys, e.g. steel alloys containing aluminium
• C23C 8/18 - Oxidising of ferrous surfaces
• C23C 8/26 - Nitriding of ferrous surfaces
• C23C 28/04 - Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of main groups , or by combinations of methods provided for in subclasses and only coatings of inorganic non-metallic material

Abstract

The present disclosure relates to a hybrid thrust bearing that combines an airfoil bearing and a magnetic bearing to support a rotating shaft with a disk-shaped thrust disk, and the magnetic bearing includes a disk-shaped housing into which the rotation shaft is inserted through a hole formed in a center and facing the thrust disk, a ring-shaped inner pole part formed around the hole on one side of the housing facing the thrust disk, a ring-shaped outer pole part disposed outside the inner pole part, an attachment part provided between the inner pole part and the outer pole part, and a coil stored in the attachment part, wherein a part of the airfoil bearing is inserted into the attachment part.

IPC Classes  ?

• F16C 32/04 - Bearings not otherwise provided for using magnetic or electric supporting means
• F16C 17/04 - Sliding-contact bearings for exclusively rotary movement for axial load only

Abstract

The present invention relates to: a novel antibody capable of binding to endoglin, or an antigen-binding fragment; and various uses thereof.

IPC Classes  ?

• C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
• A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
• C07K 14/705 - ReceptorsCell surface antigensCell surface determinants
• A61K 39/00 - Medicinal preparations containing antigens or antibodies
• A61P 35/00 - Antineoplastic agents

Abstract

The present invention relates to a method and process for preparing hydrogen peroxide, and more particularly, to a photochemical hydrogen peroxide preparation process performed by combining photoautoxidation and photocatalytic reactions in an organic reaction solution to which a catalytic amount of water is added using solar light as a main energy source.

IPC Classes  ?

• C01B 15/026 - Preparation from organic compounds from alcohols
• B01J 31/06 - Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing polymers
• B01J 35/00 - Catalysts, in general, characterised by their form or physical properties

Abstract

There is provided a method and an apparatus for diagnosing an object placement error by using an artificial neural network by which feature data of the (N+1)-th stage among the feature data of a plurality of stages is generated by using any one feature data among a plurality of feature data generated in an operation process of a main network and feature data of the plurality of stages, and a placement error of at least one object is diagnosed by using an artificial neural network of a new structure, and thus, the diagnosis accuracy of a placement error of an object that is difficult to detect an edge, such as a transparent vial, may be greatly increased.

IPC Classes  ?

• G06V 10/98 - Detection or correction of errors, e.g. by rescanning the pattern or by human interventionEvaluation of the quality of the acquired patterns
• G06V 10/82 - Arrangements for image or video recognition or understanding using pattern recognition or machine learning using neural networks